Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oji

Showing results (481-490 of 589) with videos related to

Pageof 59
Sort By:
Plos One|June 20, 2015
Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 IsoformsNaoya Tatsumi, Nozomi Hojo, Hiroyuki Sakamoto, et al.
Leukemia|December 17, 2013
In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunityJ Nakata, K Nakano, A Okumura, et al.
Oncology Letters|January 24, 2022
WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccineShouq Alzaaqi, Norifumi Naka, Kenichiro Hamada, et al.
International Journal of Oncology|February 23, 2008
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumorsNaoya Tatsumi, Yusuke Oji, Naoko Tsuji, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 28, 2006
[Extensive educational program for high performance medical technologists]S Yorifuji, Y Iwatani, S Kawano, et al.
Oncogene|March 7, 2006
Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathwayK Ito, Y Oji, N Tatsumi, et al.
Epigenetics & Chromatin|November 2, 2016
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesisValerio Pazienza, Concetta Panebianco, Francesca Rappa, et al.
British Journal of Haematology|February 14, 2002
Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cellsNaoki Hosen, Yoshiaki Sonoda, Yusuke Oji, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytesFumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, et al.
Pageof 59

Showing results (481-490 of 589) with videos related to

Sort By:
Pageof 59
Plos One|June 20, 2015
Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 IsoformsNaoya Tatsumi, Nozomi Hojo, Hiroyuki Sakamoto, et al.
Leukemia|December 17, 2013
In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunityJ Nakata, K Nakano, A Okumura, et al.
Oncology Letters|January 24, 2022
WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccineShouq Alzaaqi, Norifumi Naka, Kenichiro Hamada, et al.
International Journal of Oncology|February 23, 2008
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumorsNaoya Tatsumi, Yusuke Oji, Naoko Tsuji, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 28, 2006
[Extensive educational program for high performance medical technologists]S Yorifuji, Y Iwatani, S Kawano, et al.
Oncogene|March 7, 2006
Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathwayK Ito, Y Oji, N Tatsumi, et al.
Epigenetics & Chromatin|November 2, 2016
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesisValerio Pazienza, Concetta Panebianco, Francesca Rappa, et al.
British Journal of Haematology|February 14, 2002
Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cellsNaoki Hosen, Yoshiaki Sonoda, Yusuke Oji, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytesFumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, et al.
Pageof 59